Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;12(2):90-97.
doi: 10.1007/s12609-020-00363-2. Epub 2020 Apr 4.

Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO)

Affiliations

Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO)

Laura S Dominici et al. Curr Breast Cancer Rep. 2020 Jun.

Abstract

Purpose: Patient reported outcomes (PROs) are an optimal method for assessing quality of life (QOL), including physical and psychosocial health. This review summarizes PROs frequently assessed in the setting of a DCIS diagnosis.

Recent findings: Health-related QOL has generally been found to be modestly affected in women with DCIS and similar to women with invasive breast cancer. Several studies reported a substantial negative impact on sexual health and body image, including some differences based on surgery type. Some patients experience pain after treatment, although many physical symptoms resolve. The prevalence of anxiety and depression varied based on assessment timing, with symptoms improving over time. Women with DCIS often overestimate the risks associated both with DCIS and invasive cancer.

Summary: PROs provide critical information regarding the experiences of women following a DCIS diagnosis. Continued inclusion of PROs in clinical trials is warranted, further informing treatment decisions and adequately preparing patients for what to expect following treatment.

Keywords: DCIS; physical well-being; psychosocial well-being; quality of life; risk perceptions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Laura Dominici and Shoshana Rosenberg declare no conflicts of interest relevant to this manuscript.

Similar articles

Cited by

References

    1. American Cancer Society. Breast Cancer Facts & Figures 2019-2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... Accessed April 1, 2020.
    1. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. JAMA Oncol. 2015;1(7):888–96. doi:10.1001/jamaoncol.2015.2510. - DOI - PubMed
    1. Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER et al. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. J Natl Cancer Inst. 2015;107(12):djv263. doi:10.1093/jnci/djv263. - DOI - PMC - PubMed
    1. Rutter CE, Park HS, Killelea BK, Evans SB. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States. Ann Surg Oncol. 2015;22(7):2378–86. doi:10.1245/s10434-014-4334-x. - DOI - PubMed
    1. Miller ME, Muhsen S, Olcese C, Patil S, Morrow M, Van Zee KJ. Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy? Ann Surg Oncol. 2030;24(10):2889–97. doi:10.1245/s10434-017-5931-2. - DOI - PMC - PubMed

LinkOut - more resources